Literature DB >> 11243857

Analysis of molecular interactions of the p53-family p51(p63) gene products in a yeast two-hybrid system: homotypic and heterotypic interactions and association with p53-regulatory factors.

T Kojima1, Y Ikawa, I Katoh.   

Abstract

p51 in the p53 tumor suppressor family, also referred to as p63, encodes multiple isoforms including p51A (TAp63gamma) and p51B (TAp63alpha). The p53 protein forms a tetramer, and its stability and activity are regulated by molecular association with viral and cellular proteins and by biochemical modifications. Using a yeast two-hybrid system, the p51A and p51B isoforms were examined for homotypic and heterotypic interactions in the p53 family proteins and for their affinity to the p53-regulatory factors. Results indicate a homotypic interaction dependent on the presumed oligomerization domain of the p51 proteins. The possibility of a weak heterotypic interaction between p51 and p73 proteins was suggested, while association between p51 and p53 appeared improbable. Furthermore, unlike p53, the p51 proteins failed to display an affinity to SV40 large T antigen or MDM2-family proteins. Having several features in common with p53, the p51 proteins may function in biological processes apart from p53. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243857     DOI: 10.1006/bbrc.2001.4486

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  The evolution of MDM2 family genes.

Authors:  Jamil Momand; Alberto Villegas; Vladimir A Belyi
Journal:  Gene       Date:  2011-07-04       Impact factor: 3.688

2.  The C-terminus of p63 contains multiple regulatory elements with different functions.

Authors:  W E Straub; T A Weber; B Schäfer; E Candi; F Durst; H D Ou; K Rajalingam; G Melino; V Dötsch
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

3.  The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.

Authors:  Matthew D Westfall; Deborah J Mays; Joseph C Sniezek; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

4.  A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism.

Authors:  Zach Serber; Helen C Lai; Annie Yang; Horng D Ou; Martina S Sigal; Alexander E Kelly; Beatrice D Darimont; Pascal H G Duijf; Hans Van Bokhoven; Frank McKeon; Volker Dötsch
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

5.  SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG.

Authors:  A R M Ruhul Amin; Vijay S Thakur; Rajib K Paul; Gen Sheng Feng; Cheng-Kui Qu; Hasan Mukhtar; Munna L Agarwal
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-16       Impact factor: 11.205

Review 6.  Alterations of p63 and p73 in human cancers.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Subcell Biochem       Date:  2014

7.  Functional interplay between MDM2, p63/p73 and mutant p53.

Authors:  M H Stindt; P A J Muller; R L Ludwig; S Kehrloesser; V Dötsch; K H Vousden
Journal:  Oncogene       Date:  2014-11-24       Impact factor: 9.867

Review 8.  Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2.

Authors:  Toshinori Ozaki; Mizuyo Nakamura; Osamu Shimozato
Journal:  Biomolecules       Date:  2015-10-23

Review 9.  p53, p63 and p73 in the wonderland of S. cerevisiae.

Authors:  Marc Blondel; Cécile Voisset; Olivier Billant
Journal:  Oncotarget       Date:  2017-06-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.